Gynecologic Oncology

Radical Hysterectomy: Lessons in Risk Reduction
pp. 129-132(4)
Author: Orr J.W.

Changes in the Demographics and Perioperative Care of Stage IA₂/IB₁ Cervical Cancer over the Past 16 Years
pp. 133-137(5)
Authors: Covens A.; Rosen B.; Murphy J.; Laframboise S.; DePetrillo A.D.; Lickrish G.; Colgan T.; Chapman W.; Shaw P.

Epitope Recognition by Anti-cathepsin D Autoantibodies in Endometrial Cancer Patients
pp. 138-143(6)
Authors: Bosscher J.R.; Gercel-Taylor C.; Watkins C.S.; Taylor D.D.

A Vaginal and Extraperitoneal Approach to Surgically Stage Patients with Endometrial Cancer
pp. 144-149(6)
Authors: Silver D.F.; Wheeless C.R.; Abbas F.M.

Analysis of Treatment Failures and Survival of Patients with Fallopian Tube Carcinoma: A Cooperation Task Force (CTF) Study
pp. 150-159(10)
Authors: Gadducci A.; Landoni F.; Sartori E.; Maggino T.; Zola P.; Gabriele A.; Rossi R.; Cosio S.; Fanucchi A.; Tisi G.

Prognostic Parameters in Endometrial Stromal Sarcoma: A Clinicopathologic Study in 31 Patients
pp. 160-165(6)
Authors: Bodner K.; Bodner-Adler B.; Obermair A.; Windbichler G.; Petru E.; Mayerhofer S.; Czerwenka K.; Leodolter S.; Kainz C.; Mayerhofer K.

Caveolin-1 Expression in Advanced-Stage Ovarian Carcinoma- A Clinicopathologic Study
pp. 166-171(6)
Authors: Davidson B.; Nesland J.M.; Goldberg I.; Kopolovic J.; Gotlieb W.H.; Bryne M.; Ben-Baruch G.; Berner A.; Reich R.

A Novel Amplification at 17q21-23 in Ovarian Cancer Cell Lines Detected by Comparative Genomic Hybridization
pp. 172-177(6)
Authors: Watanabe T.; Imoto I.; Kosugi Y.; Ishiwata I.; Inoue S.; Takayama M.; Sato A.; Inazawa J.

Apoptosis and the Expression of Bcl-2 and Bax in Patients with Endometrioid, Clear Cell, and Serous Carcinomas of the Uterine Endometrium
pp. 178-183(6)
Authors: Kokawa K.; Shikone T.; Otani T.; Nishiyama R.; Ishii Y.; Yagi S.; Yamoto M.

Bcl-2 Exerts a pRb-Mediated Cell Cycle Inhibitory Function in HEC1B Endometrial Carcinoma Cells
pp. 184-192(9)
Authors: Crescenzi E.; Palumbo G.

Postoperative Vaginal Vault Brachytherapy for Node-Negative Stage II (Occult) Endometrial Carcinoma
pp. 193-195(3)
Authors: Ng T.Y.; Nicklin J.L.; Perrin L.C.; Cheuk R.; Crandon A.J.

Tumor Distribution and Survival in Six Patients with Brain Metastases from Cervical Carcinoma
pp. 196-200(5)
Authors: Mahmoud-Ahmed A.S.; Suh J.H.; Barnett G.H.; Webster K.D.; Kennedy A.W.

Chronic Administration of Single-Agent Paclitaxel in Gynecologic Malignancies
pp. 201-205(5)
Authors: Rohl J.; Kushner D.; Markman M.

The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer
pp. 206-212(7)
Authors: Campos S.M.; Penson R.T.; Mays A.R.; Berkowitz R.S.; Fuller A.F.; Goodman A.; Matulonis U.A.; Muzikansky A.; Seiden M.V.

A Phase II Study of Topotecan in Patients with Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
pp. 213-215(3)
Authors: Muderspach L.I.; Blessing J.A.; Levenback C.; Moore J.L.

Repetitive High-Dose Topotecan, Carboplatin, and Paclitaxel with Peripheral Blood Progenitor Cell Support in Previously Untreated Ovarian Cancer: Results of a Phase I Study
pp. 216-224(9)
Authors: Prince H.M.; Rischin D.; Quinn M.; Allen D.; Planner R.; Neesham D.; Gates P.; Davison J.

Comparison of Three Risk of Malignancy Indices in Evaluation of Pelvic Masses
pp. 225-229(5)
Authors: Manjunath A.P.; Pratapkumar; Sujatha K.; Vani R.

Accuracy of Intraoperative Frozen Section Diagnosis of Ovarian Tumors
pp. 230-232(3)
Authors: Pinto P.B.C.; Andrade L.A.L.A.; Derchain S.F.M.

Time since Last Birth and the Risk of Ovarian Cancer
pp. 233-236(4)
Authors: Chiaffarino F.; Parazzini F.; Negri E.; Benzi G.; Scarfone G.; Franceschi S.; La Vecchia C.

Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian Cancer
pp. 237-241(5)
Authors: Munkarah A.; Levenback C.; Wolf J.K.; Bodurka-Bevers D.; Tortolero-Luna G.; Morris R.T.; Gershenson D.M.

The Role of p27 in Endometrial Carcinoma
pp. 242-246(5)
Authors: Nycum L.R.; Smith L.M.; Farley J.H.; Kost E.R.; Method M.W.; Birrer M.J.

Genetic Origin of Malignant Trophoblastic Neoplasms Analyzed by Sequence Tag Site Polymorphic Markers
pp. 247-253(7)
Authors: Shahib N.; Martaadisoebrata D.; Kondo H.; Zhou Y.; Shinkai N.; Nishimura C.; Kiyoko K.; Matsuda T.; Wake N.; Kato H.D.

The Effects of Sex, Menstrual Cycle, and Oral Contraceptives on the Number and Activity of Natural Killer Cells
pp. 254-262(9)
Authors: Yovel G.; Shakhar K.; Ben-Eliyahu S.

CYP1A1, GSTM1, and GSTT1 Polymorphisms and the Risk of Cervical Squamous Intraepithelial Lesions in a Multiethnic Population
pp. 263-269(7)
Authors: Goodman M.T.; McDuffie K.; Hernandez B.; Bertram C.C.; Wilkens L.R.; Guo C.; Seifried A.; Killeen J.; Le Marchand L.

Importance of Urodynamic Study before Radical Hysterectomy for Cervical Cancer
pp. 270-272(3)
Authors: Lin H.-H.; Yu H.-J.; Sheu B.-C.; Huang S.-C.

Analysis of FIGO Stage IIIc Endometrial Cancer Patients
pp. 273-278(6)
Authors: McMeekin D.S.; Lashbrook D.; Gold M.; Johnson G.; Walker J.L.; Mannel R.

Extended Surgical Staging for Uterine Papillary Serous Carcinoma: Survival Outcome of Locoregional (Stage I-III) Disease
pp. 279-286(8)
Authors: Bristow R.E.; Asrari F.; Trimble E.L.; Montz F.J.

Breast Cancer Risk Assessment in Indigent Women at a Public Hospital
pp. 287-290(4)
Authors: Abu-Rustum N.R.; Herbolsheimer H.

Lysophospholipids Increase Interleukin-8 Expression in Ovarian Cancer Cells
pp. 291-300(10)
Authors: Schwartz B.M.; Hong G.; Morrison B.H.; Wu W.; Baudhuin L.M.; Xiao Y.-J.; Mok S.C.; Xu Y.

The Expression and Action of Granulocyte Macrophage-Colony Stimulating Factor and Its Interaction with TGF- in Endometrial Carcinoma
pp. 301-309(9)
Authors: Ripley D.; Tang X.-M.; Ma C.; Chegini N.

Term Delivery Following Conservative Treatment for Villoglandular Papillary Adenocarcinoma of the Uterine Cervix: Report of a Case and Analysis of the Literature
pp. 310-313(4)
Authors: Hoffman J.S.; Bazzurini L.; Laird L.; Murphy J.C.; Magriples U.; Lewis J.

Late Recurrence in Ovarian Dysgerminoma with Successful Response to Standard Adjuvant Chemotherapy: A Case Report and Review of the Literature
pp. 314-317(4)
Authors: Jeyakumar A.; Cabeza R.; Hindenburg A.

Sclerosing Stromal Tumor in an Accessory Ovary
pp. 318-319(2)
Authors: Andrade L.A.L.A.; Gentilli A.L.C.; Polli G.

Sarcoma in Association with Multimodality Management of Vulvar Cancer: Two Case Reports
pp. 320-323(4)
Authors: Hyde S.; Uitterhoeve L.J.; Schilthuis M.S.; ten Kate F.J.W.; van der Velden J.

Inguinal Lymph Node Metastasis: An Unusual Presentation of Fallopian Tube Carcinoma
pp. 324-325(2)
Authors: Winter-Roach B.A.; Tjalma W.A.; Nordin A.J.; Naik R.; de Barros Lopes A.; Monaghan J.M.

Cellular Angiofibroma of the Vulva
pp. 326-329(4)
Authors: Lane J.E.; Walker A.N.; Mullis E.N.; Etheridge J.G.

Impact on Survival Following Successful Neoadjuvant Chemotherapy and Radical Surgery for Stage IIb Bulky and Stage IIIb Cervical Cancer
pp. 330-331(2)
Authors: Sugiyama T.; Hasuo Y.; Nishida T.; Kamura T.

Phase II Trial of Topotecan, Carboplatin, and Paclitaxel as Front-Line Therapy in Suboptimal Advanced Epithelial Ovarian Cancer
pp. 331-333(3)
Authors: Bolis G.; Scarfone G.; Villa A.; Parazzini F.

Effects of Shakuyaku-kanzo-to on Muscle Pain from Combination Chemotherapy with Paclitaxel and Carboplatin
pp. 333-334(2)
Authors: Yamamoto K.; Hoshiai H.; Noda K.

Clinical Radiation Oncology. Edited by L. L. Gunderson and J. E. Tepper
pp. 335-335(1)
Author: Russell A.H.

Gynecologic Oncology: Principles and Practice of Chemotherapy. Edited by Gunter Deppe and Vicki Baker
pp. 335-336(2)
Author: Look K.Y.

Clinical Picture of Women with Early Stage Ovarian Cancer - Volume 75, Number 3 (1999), pages 476-479
pp. 337-337(1)
Authors: Eltabbakh G.H.; Yadev P.R.; Morgan A.

3rd Biennial International Meeting of the Flemish Gynaecological Oncology Group (FGOG)
pp. 338-338(1)

7th International Meeting on Psychosocial Aspects of Genetic Testing for Hereditary Breast and/or Ovarian Cancer (HBOC) and Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
pp. 339-339(1)

Papers to Appear in Forthcoming Issues
pp. 340-340(1)